Rho-kinase inhibitor upregulates migration by altering focal adhesion formation via the Akt pathway in colon cancer cells

Adachi, 2007, The inhibitory effect of (−)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells, Cancer Res., 67, 6493, 10.1158/0008-5472.CAN-07-0411 Adachi, 2008, (−)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells, Carcinogenesis, 29, 1986, 10.1093/carcin/bgn128 Adachi, 2009, p38 MAP kinase controls EGF receptor downregulation via phosphorylation at Ser1046/1047, Cancer Lett., 277, 108, 10.1016/j.canlet.2008.11.034 Adachi, 2009, (−)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells, Carcinogenesis, 30, 1544, 10.1093/carcin/bgp166 Bar-Sagi, 2000, Ras and Rho GTPases: a family reunion, Cell, 103, 227, 10.1016/S0092-8674(00)00115-X Brew, 2009, Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity, Int. J. Cancer, 124, 2294, 10.1002/ijc.24210 Burridge, 1981, Are stress fibres contractile?, Nature, 294, 691, 10.1038/294691a0 Burridge, 1996, Focal adhesions, contractility, and signaling, Annu. Rev. Cell Dev. Biol., 12, 463, 10.1146/annurev.cellbio.12.1.463 Cross, 1995, Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B, Nature, 378, 785, 10.1038/378785a0 Diaz-Rubio, 2006, Vascular endothelial growth factor inhibitors in colon cancer, Adv. Exp. Med. Biol., 587, 251, 10.1007/978-1-4020-5133-3_20 Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat. Rev. Cancer, 2, 161, 10.1038/nrc745 Fritz, 1999, Rho GTPases are over-expressed in human tumors, Int. J. Cancer, 81, 682, 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B Humphries, 2007, Vinculin controls focal adhesion formation by direct interactions with talin and actin, J. Cell Biol., 179, 1043, 10.1083/jcb.200703036 Itoh, 1999, An essential part for Rho-associated kinase in the transcellular invasion of tumor cells, Nat. Med., 5, 221, 10.1038/5587 Izawa, 1998, Possible involvement of the inactivation of the Rho–Rho-kinase pathway in oncogenic Ras-induced transformation, Oncogene, 17, 2863, 10.1038/sj.onc.1202213 Joshi, 2008, Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion, Cancer Res., 68, 8210, 10.1158/0008-5472.CAN-08-0343 Kerbel, 2002, Clinical translation of angiogenesis inhibitors, Nat. Rev. Cancer, 2, 727, 10.1038/nrc905 Matsui, 1996, Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho, EMBO J., 15, 2208, 10.1002/j.1460-2075.1996.tb00574.x McHardy, 2004, The tumor invasion inhibitor dihydromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchange, Cancer Res., 64, 1468, 10.1158/0008-5472.CAN-03-2733 Nakashima, 2010, Rho-kinase regulates negatively the epidermal growth factor-stimulated colon cancer cell proliferation, Int. J. Oncol., 36, 585 Pellegrin, 2007, Actin stress fibres, J. Cell Sci., 120, 3491, 10.1242/jcs.018473 Pourgholami, 2008, Inhibitors of vascular endothelial growth factor in cancer, Cardiovasc. Hematol. Agents Med. Chem., 6, 343, 10.2174/187152508785909528 Ridley, 2003, Cell migration: integrating signals from front to back, Science, 302, 1704, 10.1126/science.1092053 Riento, 2003, Rocks: multifunctional kinases in cell behaviour, Nat. Rev. Mol. Cell Biol., 4, 446, 10.1038/nrm1128 Sahai, 1999, Transformation mediated by RhoA requires activity of ROCK kinases, Curr. Biol., 9, 136, 10.1016/S0960-9822(99)80067-0 Sahai, 2002, RHO-GTPases and cancer, Nat. Rev. Cancer, 2, 133, 10.1038/nrc725 Salhia, 2005, Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1, Cancer Res., 65, 8792, 10.1158/0008-5472.CAN-05-0160 Shimokawa, 2007, Development of Rho-kinase inhibitors for cardiovascular medicine, Trends Pharmacol. Sci., 28, 296, 10.1016/j.tips.2007.04.006 Vecchiarelli-Federico, 2010, Vascular endothelial growth factor—a positive and negative regulator of tumor growth, Cancer Res., 70, 863, 10.1158/0008-5472.CAN-09-3592 Wozniak, 2004, Focal adhesion regulation of cell behavior, Biochim. Biophys. Acta, 1692, 103, 10.1016/j.bbamcr.2004.04.007